{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.1444.3.196",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2021-05-21T01:00:52.000-04:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.196",
  "version" : "20210521",
  "name" : "Brentuximab Vedotin Injectable",
  "status" : "active",
  "date" : "2021-05-21T01:00:52-04:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "concept" : [{
        "code" : "1147323",
        "display" : "brentuximab vedotin 50 MG Injection"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:14c92762-7e76-4e53-9887-a247b6b3d63d",
    "timestamp" : "2022-09-27T18:34:50-04:00",
    "total" : 1,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "1147323",
      "display" : "brentuximab vedotin 50 MG Injection"
    }]
  }
}